Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
AbbVie to Invest $380 Million in Chicago to Further Expand US API Manufacturing
AbbVie announced a new $380 million investment to build two advanced active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago campus. These facilities, expected to be operational in 2029, will utilize AI and advanced manufacturing to support next-generation neuroscience and obesity medications, strengthening AbbVie’s US manufacturing capabilities. This investment contributes to AbbVie’s $100 billion commitment to US R&D and capital investments over the next decade, following recent plans to expand API manufacturing and acquire a device manufacturing facility in Arizona.